1. Ahthee, L., Paasonen, M. K.: Potentiation of 5-hydroxytryptamine release from platelets by desmethylation of chlorpromazine and related agents. Acta pharmacol. (Kbh.) 26, 213, (1968).
2. Akera, T., Brody, T. M.: Inhibition of brain sodium- and potassium-stimulated adenosine triphosphatase activity by chlorpromazine free radical. Molec. Pharmacol. 4, 600 (1968).
3. ?? The interaction between chlorpromazine free radical and microsomal sodium- and potassium-activated adenosine triphosphatase from rat brain. Molec. Pharmacol. 5, 605 (1969).
4. ?? Inhibitory sites on sodium- and potassium-activated adenosine triphosphate for chlorpromazine free radical and ouabain. Molec. Pharmacol. 6, 557 (1970).
5. Bente, D., Hippius, H., Pöldinger, W., Stach, K.: Chemische Konstitution und klinische Wirkung von antidepressiven Pharmaka. Arzneimittel-Forsch. 14, 487 (1964).